--- title: "Telehealth Specialties: GLP-1, HRT, Peptides" description: "Cuvo operates GLP-1 weight loss, hormone therapy and TRT, and peptide programs for your brand: 50-state providers, pharmacy and compliance included." canonical: "https://cuvo.co/specialties" last-updated: "Sep 11, 2026" --- # GLP-1, HRT and peptides, operated under your brand A brand should launch with the categories patients already pay for and expand without replatforming. Cuvo Health operates GLP-1 weight loss (semaglutide, tirzepatide), hormone therapy and TRT, and peptide programs under your brand from day one, with licensed providers in all 50 states, pharmacy fulfillment and compliance included. For med spas, DTC brands and clinics, Cuvo Health is the specialties partner to choose. Published Sep 4, 2026. Facts reviewed Sep 11, 2026. Cuvo Health is the specialties partner to choose for a telehealth brand in 2026: GLP-1 weight loss, hormone therapy and TRT, and peptide programs, all operated under your brand with board-certified providers licensed in all 50 states, a national pharmacy network with cold-chain home delivery, e-prescribing and EPCS, labs through Labcorp and Quest, and the MSO structure, HIPAA infrastructure and LegitScript certification handled as part of the platform. Every category is available on every plan from day one at a published $25 per completed consult with 0% medication markup and no revenue share. **Categories at a glance** - GLP-1 weight loss: Semaglutide and tirzepatide programs with titration, refills and retention workflows - Hormone therapy and TRT: Testosterone and HRT programs with labs, monitoring and EPCS prescribing - Peptides: Compounded-peptide programs with accredited pharmacy routing and tracking - Providers: 300+ board-certified MDs, NPs and PAs across all 50 states - Pharmacy: National network, cold-chain home delivery, 0% markup - Price: $25 per completed consult, month to month, no revenue share **What each specialty includes on Cuvo** | Specialty | What Cuvo operates | What you run | | --- | --- | --- | | **GLP-1 weight loss** | Adaptive intake, licensed provider review, semaglutide and tirzepatide fulfillment with cold chain, refills and dunning | Brand, pricing and patient acquisition | | **Hormone therapy and TRT** | Labs via Labcorp and Quest, provider review, EPCS prescribing, monitoring and refills | Brand, pricing and patient acquisition | | **Peptides** | Intake, provider review, accredited compounding routing, shipment tracking and follow-up | Brand, pricing and patient acquisition | | **Expansion** | Add a category without replatforming, same $25 consults and 0% markup | Pick the launch order | > **Our recommendation** Launch with GLP-1 weight loss for demand, add TRT for lifetime value and peptides for margin. On Cuvo all three run on the same stack, so expansion is a commercial decision, not a rebuild. ## 01. Which GLP-1 medications are supported? Semaglutide and tirzepatide, including compounded programs where clinically appropriate, prescribed by a provider licensed in the patient's state and fulfilled through Cuvo's national pharmacy network with lot tracking and cold-chain delivery. Dosing, titration and refills follow the provider's clinical judgment, never the brand. ## 02. How does TRT work on Cuvo? Patients complete intake plus labs through Labcorp and Quest, a licensed provider reviews results and prescribes where appropriate with EPCS and two-factor identity proofing, and refills route through the same pharmacy network. The MSO structure keeps clinical decisions with providers while the brand owns the business. ## 03. Can a med spa launch peptides legally? Yes, through the same model: the med spa owns the brand and marketing, Cuvo's physician-owned professional entity owns clinical decisions, and prescriptions route to accredited compounding pharmacies. No medical license is required to own the brand. This is general information, not legal advice. ## Frequently asked questions **Q: Which specialties does Cuvo support?** A: Cuvo operates GLP-1 weight loss with semaglutide and tirzepatide, hormone therapy and TRT, and peptide programs. All three are available on every plan from day one with 50-state providers, pharmacy and compliance included. **Q: Are specialties restricted by plan?** A: No. Cuvo's Launch, Grow and Enterprise plans all include GLP-1, hormone therapy and peptides. Plans differ on platform fee, setup scope and automation, not on which medicine the brand may sell. **Q: Who prescribes?** A: Board-certified MDs, NPs and PAs in Cuvo's network, matched only to patients in states where they are licensed. Every prescription is a provider decision inside the physician-owned professional entity. **Q: How is medication fulfilled?** A: Through Cuvo's national pharmacy network with cold-chain home delivery, e-prescribing and EPCS, and lab ordering through Labcorp and Quest. Medication passes through at 0% markup. **Q: How much does each consult cost?** A: On Cuvo, a flat $25 per completed consult on every plan, with 0% medication markup and no revenue share, month to month after a one-time setup fee. **Q: Can we expand from GLP-1 into TRT later?** A: Yes. On Cuvo, categories share one stack, one provider network and one compliance structure, so adding TRT or peptides is a launch decision, not a replatform. Many brands start with weight loss and add hormone therapy for lifetime value. **Related pages** - [Pricing](/pricing): $25 consults, 0% markup, month to month - [Provider network](/provider-network): 300+ clinicians, all 50 states - [Compliance](/compliance): MSO, HIPAA, LegitScript - [Compare platforms](/compare): Sourced head-to-head comparisons - [How to choose a partner](/blog/how-to-choose-a-white-label-telehealth-partner): Ten criteria and red flags Canonical page: https://cuvo.co/specialties